Skip to main content
Clinical Trials/NCT03035669
NCT03035669
Unknown
Not Applicable

Effects of Mindfulness Training on Emotion Regulation and Social Cognition, a Psychophysiological and Neuroimaging Randomized Controled Study.

Humboldt-Universität zu Berlin1 site in 1 country60 target enrollmentNovember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stress, Psychological
Sponsor
Humboldt-Universität zu Berlin
Enrollment
60
Locations
1
Primary Endpoint
Changes in resting state functional connectivity within brain networks. Measured by significant changes in intrinsic functional connectivity parameters, estimated from the resting state BOLD signal, during functional magnetic resonance imaging.
Last Updated
9 years ago

Overview

Brief Summary

The present study will investigate the effects of a mindfulness training on emotion regulation and social cognition, using several psychological, behavioral, psychophysiological and neuroimaging methods.

Detailed Description

The aim of the present study is to evaluate the impact of a mindfulness intervention, particularly the mindfulness-based stress reduction (MBSR), on the capacities of emotion regulation and social cognition, in caring/helping professions which are vulnerable to stress. In the context of a longitudinal intervention study, a randomized controlled trial, the efficacy of the MBSR to increase the capacity for self-emotion regulation, empathic attunement, and compassion capacities will be measured. For doing this, several psychological, behavioral, psychophysiological and neuroimaging brain measurements will be used.

Registry
clinicaltrials.gov
Start Date
November 2016
End Date
June 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Simon Guendelman

Medical doctor, doctorate candidate.

Humboldt-Universität zu Berlin

Eligibility Criteria

Inclusion Criteria

  • Healthy volunteers: Men or women
  • Right-handed
  • Normal or corrected-to-normal visión
  • German as a first language
  • No history of neurological or psychiatric problems, or use of controlled medication that might interfere with emotion or attention.
  • No symptoms of claustrophobia
  • Written informed consent form to participate in the study and neuro-imaging experiment.

Exclusion Criteria

  • Chemical dependence, including nicotine and alcohol
  • Dementia or psychotic condition.
  • Depression or use of antidepressants
  • Pregnant or breast-feeding women
  • Prior MBSR class or regularly practicing mindfulness meditation (or yoga) for three or more months.
  • Non-controlled severe medical disease that might interfere with the performance of the study, such as neoplasias, cardiopathies, digestive pathologies, diabetes mellitus type I or type II
  • Neoplasias in the central nervous system
  • Tremor or dystonia in cephalic segment that hinders the performance of the MRI study (tremor equal to or higher than 3 in each corporal segment, according to the UPDRS scale)
  • Fulfillment of any criterion of contraindication for the MRI exam (for instance, metallic implants, claustrophobia, pregnancy, use of pacemaker; intracranial aneurism clip; cochlear implants).
  • Presence of odontological devices that might disturb the magnetic field or any sources of variation of the magnetic susceptibility

Outcomes

Primary Outcomes

Changes in resting state functional connectivity within brain networks. Measured by significant changes in intrinsic functional connectivity parameters, estimated from the resting state BOLD signal, during functional magnetic resonance imaging.

Time Frame: first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.

Activation changes in emotions related brain regions. Measured by significant changes in the BOLD (blood oxygenated level dependent) signal from task based functional magnetic resonance imaging.

Time Frame: first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.

Secondary Outcomes

  • Changes in psychophysiological measurements of stress (vagal component)(first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.)
  • Changes in resting state functional connectivity between inter-networks connectivity.(first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.)
  • Changes in personality functioning.(first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.)
  • Changes in social functioning(first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.)
  • Changes in regional brain morphometry in stress processing related areas. Measured by significant changes in regional grey matter density estimated from structural magnetic resonance imaging.(first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.)
  • Changes in psychophysiological measurements of stress (sympathetic component)(first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.)
  • Behavioural tasks: mind-wandering task(first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.)
  • Experience Sampling of emotional tolerance(first acquisition period during 3 weeks before the intervention, last acquisition period during 3 weeks after the intervention. And during the intervention period everyday.)
  • Behavioural tasks: empathy test.(first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.)
  • Changes in self-reported affective states(first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.)

Study Sites (1)

Loading locations...

Similar Trials